Low sensitivity of the tourniquet test for differential diagnosis of dengue: an analysis of 28,000 trials in patients by Nathália Barbosa Furlan et al.
RESEARCH ARTICLE Open Access
Low sensitivity of the tourniquet test for
differential diagnosis of dengue: an analysis
of 28,000 trials in patients
Nathália Barbosa Furlan1, Caroline Tukasan1, Cássia Fernanda Estofolete1,2, Maurício Lacerda Nogueira2
and Natal Santos da Silva1,2,3,4*
Abstract
Background: The aim of this study was to evaluate the utility of the tourniquet test (TT) for dengue diagnosing. To
our knowledge, no previous study with such a large sample, of this duration, with as many laboratory methods
referenced, or relating the results of the TT to the 2009 WHO classification of severity has been conducted thus far.
Methods: In this study, we analyzed the records of 119,589 suspected dengue cases in a Brazilian city, with 30,670
confirmed cases. The Cohen’s Kappa test was applied to evaluate the degree of agreement between the tests, and
the sensitivity and specificity was calculated for the TT.
Results: Twenty-eight thousand six hundred thirty-five TT were performed. No association between the outcome of
the TT and greater severity of infection, according to the 2009 guideline, was observed (P = 0.28); furthermore,
relevant agreement with the final diagnosis (κ = 0.01; 95 % CI = 0.00 to 0.02) or individually with the IgM enzyme-
linked immunoassay was not observed (κ = 0.05; 95 % CI = 0.04 to 0.06), and was even lower with PCR (κ = 0.27;
95 % CI = 0.06 to 0.49). Most importance of the TT was shown in relation to specificity (88.9 %; 95 % CI = 0.88 to
0.89) and negative predictive value (70.3 %; CI 95 % = 0.70 to 0.71).
Conclusions: TT was more effective in detecting cases that were truly negative than positive. These results suggest
that the TT should not be used as diagnosis of dengue.
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Background
The dengue virus (DENV) is the most important arbovirus
in the world in terms of morbidity, mortality, and clinical
implications [1]. Between 2.5 and 3.6 billion people, more
than 50 % of the world’s population, are currently living
with the risk of infection. The incidence is even higher in
tropical and subtropical countries where environmental
conditions favor the proliferation of the Aedes mosquitoes
[2–5]. However, this disease is also advancing into devel-
oped countries, where the occurrence of dengue has not
been previously registered, such as the United States of
America [6–8], Japan [9–11], and France [12].
Dengue is caused by four types of DENV: DENV-1,
DENV-2, DENV-3, and DENV-4 [13]. More recently, a
new serotype, DEN-5, was identified in serum samples
collected during an epidemic of dengue in Malaysia in
2007, still under study [14]. All virus strains can lead to
all forms of dengue infection, from asymptomatic to
severe, or even fatal. However, it is unclear why some
dengue cases progress to severe forms. Although there
are controversies in the literature, sequential infections
of different serotypes of DENV have an important role
[15–17]. Still, even during epidemics in populations with
high levels of antibodies against DENV, the proportion
of severe dengue cases is low [18], suggesting that other
risk factors are involved in the severity of the disease.
The main feature of the severe forms of the disease is in-
creased vascular permeability resulting in plasma leakage
from the intravascular compartment to the extravascular
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space [17, 19, 20]. Fluid loss, leading to hypovolemic
shock, thrombocytopenia, coagulation abnormalities, and
bleeding are also features of severe dengue disease [21].
The diagnosis of the infection is particularly difficult in
mild forms of the disease, especially when differentiating
dengue from other febrile illnesses. The risk of swift
progression from mild to severe forms of dengue infec-
tion, which may require rapid resuscitation measures,
demonstrates that accurate and early diagnosis through
other methods is relevant in the absence of serologic and
virologic confirmation [22–24].
In 1997, the World Health Organization (WHO) listed
the tourniquet test (TT) as a criterion for dengue
hemorrhagic fever, and that the positive test reflects both
capillary fragility and thrombocytopenia [22]. Studies
suggested that the test has a greater positivity rate in in-
dividuals with more severe forms of the disease but
cannot exclude dengue infection [25, 26].
Evaluation of the utility of TT to diagnose or exclude den-
gue has been proposed in previous studies [20, 22, 27, 28],
with mixed results. Thus, the aim of this study was to evalu-
ate the use of TT in the screening of patients with suspected
dengue and its severity, and to compare this test with
routine diagnostic methods. Accordingly, we decided to use
a relatively large sample over a considerably long time
period. We also utilized many laboratory methods for refer-
ence, including the polymerase chain reaction (PCR), and
simultaneously related results to the severity index set forth
in the 2009 WHO classification.
Methods
We have used records from the Notifiable Diseases
Information System (SINAN), a program of Brazil’s
Ministry of Health to collect notifications of all sus-
pected dengue cases in the city of São José do Rio Preto,
São Paulo, Brazil, whose population in 2010 was ap-
proximately 408,258 inhabitants. For this study, 119,589
cases notified between May 1998 and July 2012 were eli-
gible, previous to the introduction of Zika and chikungunya
virus in Brazil.
In addition to clinical evaluation by a physician, serum
samples from all patients with suspected dengue were
submitted to a diagnostic laboratory for the determin-
ation of dengue based on an IgM immunoglobulin
enzyme-linked immunoassay (ELISA), non-structural
protein 1 (NS1), or DENV PCR, depending on which
test was being commonly used at the time of the case.
Case definition
For notification purposes, in accordance with the criteria
of Brazil’s Ministry of Health, suspected cases of dengue
included all patients with acute febrile illness lasting up to
seven days, accompanied by at least two of the following
signs or symptoms: headache, retro-orbital pain, myalgia,
arthralgia, prostration or rash associated with the presence
of bleeding, positive epidemiological history, residence
within a dengue transmission or Aedes aegypti endemic
area in the last 15 days.
The clinical classification used retrospectively in this
study for statistical purposes was based on the WHO
guideline (2009) to distinguish between dengue and se-
vere dengue. The first one is suspected in patients who
live or have traveled to a dengue-endemic area, with
fever and two or more of the following: nausea and/or
vomiting, rash, pain (headache, retro-orbital pain, myal-
gia, and/or arthralgia), and a positive TT or leukopenia.
Abdominal pain, persistent vomiting, fluid retention,
mucosal bleeding, lethargy, hepatomegaly greater than
2 cm, increasing hematocrit, and rapid decrease in plate-
let count are suggestive of dengue and serve as warning
signs of severe dengue. Severe dengue is characterized
by severe plasma leakage leading to shock or respiratory
distress, severe bleeding, impairment of organs with a
pronounced increase of aminotransferases, altered con-
sciousness level, or heart failure.
Statistical analysis
All reported cases (negative or positive for DENV) in
which the TT was performed were evaluated, and this
variable was studied in relation to the actual outcome,
i.e., confirmed dengue on the basis of the conventional
laboratory methods as described above. For cases in
which the diagnosis of dengue was established, the per-
centage of positive TT results was evaluated over time
and according to age.
A descriptive analysis of personal and serological vari-
ables was performed and related to a hemorrhagic mani-
festation as externalized bleeding and thrombocytopenia,
defined as a platelet count of less than 100,000/mm3.
The hypothesis that TT positivity would be associated
with more severe scores of DENV infection was evalu-
ated using nonparametric Mann-Whitney U tests. How-
ever, the Pearson’s chi-square test (χ2) was performed to
check if there was a positive association between TT and
thrombocytopenia in patients with suspected dengue.
The Cohen’s Kappa coefficient (κ) was applied to meas-
ure the degree of agreement between the TT and the
final diagnosis, PCR results, and presence of IgM and
NS1. To quantify the strength of this agreement, a scale
used by Landis and Koch was proposed, where values
lower than zero show poor agreement. Specifically,
values less than zero indicate poor agreement, from 0 to
0.2 indicate slight agreement, 0.21 to 0.4 indicate fair
agreement, 0.41 to 0.6 indicate moderate agreement,
0.61 to 0.8 indicate substantial agreement, and 0.81 to
1.0 indicate almost perfect agreement [29].
Later, the sensitivity and specificity, positive predictive
value (PPV), negative predictive value (NPV), positive
Furlan et al. BMC Infectious Diseases  (2016) 16:627 Page 2 of 7
likelihood ratio, and negative likelihood ratio of the TT
were also determined. All analyses were performed using
SPSS software, version 19, and adopted a significance
level of 5 % and a confidence interval of 95 %.
Results
We analyzed 119,589 participants, with an average age of
33.3 years, with considerable dispersion (±18.1 years);
further, 65,595 (54.9 %) of the patients were female and
53,898 patients (45.1 %) were male (96 patients had no in-
formation about sex). The TT was performed in 28,635
patients (23.9 % of all notifications); 3252 (11.4 %) were
positive and 25,383 cases (88.6 %) were negative.
At least one information about hemorrhagic manifest-
ation was available for all patients undergoing to TT.
The data shows that 17,123 (59.8 %) patients had not
shown any hemorrhagic manifestations, while 11,512
(40.2 %) had one or more type of blood leakage (Table 1).
However, information about thrombocytopenia was ob-
tained in only 1930 (6.7 %) individuals. In these patients
906 (47.0 % of patients) had negative TT results without
thrombocytopenia, 269 (13.9 %) had negative TT results
with thrombocytopenia, 538 (27.9 %) had positive TT re-
sults without thrombocytopenia, and 217 (11.2 %) had
positive TT results with thrombocytopenia. Therefore,
there was a statistically significant difference between
the TT results and the thrombocytopenia count of these
patients (χ2 = 8344; P = 0.004).
The proportion of positive TT results in patients with
dengue over the years shows an increasing trend until
2008, but a decrease in subsequent years (Fig. 1). This ra-
tio was similar within age groups 0 to 14 years (11.2 %),
15 to 60 (12.1 %), and older than 60 years (11.4 %).
Of all cases with TT results, 921 (10.7 %) were dengue
without warning signs, 7410 (86.4 %) were dengue with
warning signs, 246 (2.9 %) were severe dengue, and 16
patients died. The hypothesis that there would be an as-
sociation between the TT results and a greater severity
score has not been confirmed with the Mann-Whitney
test (U = 3,826,121; P = 0.28). For this analysis, only 8577
of the 30,670 confirmed cases of dengue had the TT per-
formed, with 1026 (12.0 % of 8577) testing positive and
7551 (88.0 %) testing negative.
The TT had almost no concordance with the final diag-
nosis on the basis of the Cohen’s Kappa coefficient (κ =
0.01, CI 95 % = 0.00 to 0.02), with IgM detection by ELISA
(κ = 0.05; CI 95 % = 0.04 to 0.06), or with PCR (κ = 0.27,
CI 95 % = 0.06 to 0.49) (Table 2). The comparison between
the TT and the NS1 detection could not be carried out be-
cause only four individuals had these two tests performed
simultaneously.
Based on the final diagnosis obtained, the TT had a
sensitivity of 11.9 % (CI 95 % = 0.11 to 0.12), as opposed
to a specificity of 88.9 % (CI 95 % = 0.88 to 0.89),
indicating an ability to detect truly negative cases. In
addition, it was observed that the ability of this test to
predict if the patient was actually sick when the test was
positive was significantly lower. That is to say, the PPV
was only 31.6 % (CI 95 % = 0.31 to 0.32) while the NPV
was 70.3 % (CI 95 % = 0.70 to 0.71), showing a greater
ability to identify those individuals who really did not
have dengue when the TT was negative. However, the
positive likelihood ratio (1.08) shows that this does not
practically change the chance of the TT results being
truly positive in a population with dengue compared to
a population without the disease. A similar result was
also seen in the negative likelihood ratio (0.99), which
showed that the likelihood of a negative test result in






N (%) N (%) N (%) p-value
Epistaxisa <0.001
Present 121 (17.5) 571 (82.5) 692 (100)
Ausente 3032 (11.2) 23,954 (88.8) 26,986 (100)
Petechiaeb <0.001
Present 701 (29.7) 1663 (70.3) 2364 (100)
Absent 2445 (9,7) 22,694 (90.3) 25,139 (100)
Exanthemac <0.001
Present 1382 (18.8) 5984 (81.2) 7366 (100)
Absent 1693 (8.3) 18,762 (91.7) 20,455 (100)
Gingival bleedingd <0.001
Present 76 (19.7) 309 (80.3) 385 (100)
Absent 3073 (11.3) 24,181 (88.7) 27,254 (100)
Metrorrhagee <0.001
Present 34 (27.4) 90 (72.6) 124 (100)
Absent 1673 (15.2) 9366 (84.8) 11,039 (100)
Hematuriaf 0.15
Present 16(18.2) 72(81.8) 88(100)




Present 33 (25.6) 96 (74.4) 129 (100)
Absent 2613 (12.8) 17,732 (87.2) 20,345 (100)
Missing: there was no information for the respective
hemorrhagic manifestations
p-value: Chi-square
aMissing: 957 (3.3 %)
bMissing: 1132 (4.0 %)
cMissing: 814 (2.8 %)
dMissing: 996 (3.5 %)
e[Information about female] Missing: 4807(30.1 %)
fMissing: 8028 (28.0 %)
gMissing: 8161 (28.5 %)
Furlan et al. BMC Infectious Diseases  (2016) 16:627 Page 3 of 7
patients with dengue was not different from those with-
out the disease.
Discussion
The approach of the TT value as auxiliary method for
diagnosing dengue as presented here is something
unusual in the medical literature. The use of so many
samples over such a long period of study, and the com-
parison of the results, including the dengue severity was
never reported. About a quarter (28 635) of patients ini-
tially notified as suspected dengue fever (119,589) were
evaluated by the TT, so a considerable amount of
patients were not submitted to this test, perhaps as a
consequence of difficulties in filling the notification form
or due to non-realization of this test during the great
outbreaks of the disease. In our investigation, there was
a gradual increase in the percentage of positive TT re-
sults over the years, with a further decrease in the last
five years of the study, with similar proportions of posi-
tive test results between age groups. No association be-
tween the TT results and greater severity (according to
the 2009 guideline) was observed (P = 0.28). The TT re-
sults also failed to show relevant agreement with the
final diagnosis (κ = 0.01; 95 % CI = 0.00 to 0.02), the
ELISA-IgM results (κ = 0.05; 95 % CI = 0.04 to 0.06), and
much less with the PCR results (κ = 0.27; 95 % CI = 0.06
to 0.49). This low concordance was also justified by the
low sensitivity of the TT to diagnose dengue (11.9 %;
95 % CI = 0.11 to 0.12) and low PPV (31.6 %; 95 % CI =
0.31 to 0.32); nevertheless, it has shown most import-
ance for specificity (88.9 %; 95 % CI = 0.88 to 0.89) and
NPV (70.3 %; CI 95 % = 0.70 to 0.71).
Fig. 1 Proportion of positive tourniquet test results between 1998 and 2012 in 25,383 dengue cases
Table 2 The degree of agreement between the results of the tourniquet test and those of various laboratory methods
Tourniquet test
Positive Negative κ a(CI 95 %) Agreement
N (%) N (%)
Final diagnosis 0.01 (0.00 to 0.02) Slight
Positive 1026 (31.5) 7551 (29.7)
Negative 2226 (68.5) 17,832 (70.3)
Total 3252 (100.0) 25,383 (100.0)
ELISA(IgM) 0.05 (0.04 to 0.06) Slight
Positive 1016 (69.2 %) 7539 (53.4 %)
Negative 453 (30.8 %) 6590 (46.6 %)
Total 1469 (100.0) 14,129(100.0)
PCR 0.27 (0.06 to 0.49) Fair
Positive 20 (62.5 %) 15 (34.9 %)
Negative 12(37.5 %) 28 (65.1 %)
Total 32 (100.0) 43 (100.0)
Comparison between tourniquet test and NS1 research could not perform because there were only four patients with both tests realized
aCohen’s Kappa coefficient (confidence interval of 95 %)
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The wide clinical spectrum of infection by DENV and
the possibility of progression from mild to more severe
forms of dengue [30], which require early therapeutic
measures and are related to higher mortality, demon-
strate the need for alternative methods that can be cor-
related to this evolution and anticipate potential severity.
WHO, in its 1997 guidelines, lists the TT as a criterion
in the diagnosis of dengue hemorrhagic fever. In the
2009 guidelines, it is presented as a criterion for both
mild and severe forms of the disease. However, studies
differ in their use of the test for the diagnosis of infec-
tion by DENV and their correlation with severity. Al-
though our findings are in agreement with those found
by other authors regarding the TT’s low sensitivity and
high specificity [20, 22, 28, 31], there are findings whose
values contradict ours, reporting a sensitivity of 83 %
and specificity of 23.5 % when used in children in
Malaysia [32], suggesting that children may exhibit a dif-
ferent pattern of TT positivity compared to other age
groups. However, the finding of equal percentages of
positive TT results in both children and adults leads us
to disagree with this possibility, despite reports in the lit-
erature of different clinical manifestations in children
(mainly bleeding) [33]. For other authors, the difference
between sensitivity and specificity was practically equal,
but with the PPV lower (45 and 55 %, respectively) than
the NPV (64 and 69 %, respectively) [27].
Isolated, low PPV was found in our study with a low sen-
sitivity and high specificity; however, Ho et al. [31] reported
that PPV may reach 93.1 % when combined with leukopenia
(<4000/mm3), thrombocytopenia (<150 × 103/mm3), partial
thromboplastin time (>38 s), elevated aminotransferases
(AST/ALT >1.5), and low C-reactive protein (<20 mg/l)
[30]. According to Gregory et al. (2011), the combination of
a positive TT results and leukopenia (<5000/mm3) identified
94 % of patients with dengue in the emergency room [34].
However, leukopenia may not present in the initial stages
of dengue, which can delay the diagnosis of the disease
when utilizing this method [35]. Therefore, the assessment
isolated of the PPV, as well as the NPV, perhaps are not
good parameters for evaluation, thus requiring additional
laboratory data to make their validation stronger.
It must also be considered that the TT can be influenced
by disease progression, age, gender [27], circulating strains,
and virus circulation patterns over a determined period.
This test can also yield a positive result for other patho-
logical conditions with varying indexes, such as with typhoid
fever and Japanese encephalitis [22], although the TT has
lower sensitivity for these diseases than for dengue. In this
study, 68.5 % of patients who had dengue confirmed by
serological diagnosis showed a positive TT result. Under-
standing this condition could prevent infections with clinical
presentations similar to dengue from being misdiagnosed
and thus provide a better chance for accurate treatment in
adequate time. Such evidence shows the complexity in-
volved in the clinical diagnosis and management of dengue.
Due to the long period of study, the epidemiological con-
ditions of dengue varied, both in relation to the circulating
serotype and the number of co-circulating serotypes, which
are factors that may be related to a positive TT result. Ac-
cording to the data in Fig. 1, a significant increase in the
proportion of positive TTs can be noted until 2008, followed
by a decrease. Between the introduction of DENV in the
study area and 2008, we observed circulation of DENV-1,
−2 and −3, with a maximum of two serotypes simultan-
eously. Since 2009, there was a reintroduction of DENV-1,
followed by explosive outbreaks of DENV-1 and DENV-4
with about 20,000 suspected cases per year and the co-
circulation of three serotypes. On the other hand, DENV-3
caused the major epidemics in 2006 and 2007, followed by a
DENV-2 epidemic in 2008 [36–39]. Due to insufficient in
the database, it was not possible to correlate the data from
TTs with serotypes specifically, but the association between
serotypes and genotypes may be related to this
phenomenon. Moreover, we cannot rule out the possibility
that the TT generates a false positive in the presence of
other flaviviruses circulating in Brazil, particularly the Saint
Louis encephalitis virus, which has been associated with a
positive TT in our region [40, 41].
Indeed, in retrospective studies based on government epi-
demiological data or otherwise, the major limitation is that a
lot of information cannot be reassessed, leading to additional
reliability being placed on those individuals who collected
and recorded information, such as the performance of the
TT, which could not be directly supervised. However, it is
relatively common that nurses, laboratory technicians, or
trained doctors in Brazilian dengue-endemic areas manage
dengue cases, which implies that the results are as realistic
as possible. Additionally, inconsistent data, both in relation
to reporting, such as white blood cell count, as well as the
interpretation, were excluded from analysis in this study in
order to minimize the effect of these limitations on the find-
ings and conclusions.
Conclusions
Therefore, the TT was more effective in detecting cases
that were truly negative than positive. These results sug-
gest that the TT should not be used as diagnosis of den-
gue, however, if it is absolutely necessary to use it, as is
the case in very poor dengue endemic areas where more
sensitive and specific laboratory tests are not available,
then it to be done with great caution for screening giv-
ing rise to suspicion of dengue cases.
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